Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis
暂无分享,去创建一个
T. Ishikawa | Etsuko Iio | Yasuhito Tanaka | M. Zeniya | H. Toyoda | T. Kumada | T. Tada | K. Takaguchi | K. Tsuji